Latest Conference Articles

Investigators revealed the development of a non-invasive molecular test utilizing gene expression differences in skin diseases such as atopic dermatitis, psoriasis, and mycosis fungoides, with the potential to accurately diagnose and identify super-responders to targeted systemic therapies.

Alice Gottlieb, MD, PhD, put a spotlight on recent studies and the current psoriasis treatment armamentarium for dermatology clinicians to consider.

Susan Taylor, MD, provided insight into epidemiology, patient quality of life, clinical presentation, therapies, and more at Masterclasses in Dermatology.

Peter Lio, MD, shared alternative medicine approaches and resources that dermatologists and patients can utilize for various skin conditions.

The 2-GEP test is made of 2 biomarkers, LINC00518 and PRAME.

Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.

Among the many sessions to be held at the Winter Clinical Miami 2024 Conference in Miami Beach, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll about the upcoming conference.

Click here to answer our poll about the upcoming conference in Puerto Rico.

The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

Ablon’s session highlights include best practices for hair restoration.

Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.

An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.

Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.

Let us know if you plan to attend IMCAS World Congress 2024.

A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.

A poster from Maui Derm Hawaii revealed an even more significant disparity than researchers anticipated.

Patients with moderate to severe AD gave their opinions in a survey on treatment options and their tradeoffs. Itch control topped the list of patient concerns.

Researchers from Pyeongchon, Korea, argue that evidence points to the need for a change in the terminology of "freckling," according to a poster from Maui Derm Hawaii.

A poster presented at Maui Derm Hawaii delved into the efficacy and safety of trifarotene 50µg/g cream in acne vulgaris and PIH.

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.

The VISIBLE clinical program will create a longitudinal collection of more than 20,000 clinical images across all skin tones.

Among the many sessions to be held at the Maui Derm Hawaii 2024 conference on Maui, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll.

The Winter Clinical Hawaii session delved into a spectrum of skin conditions, treatments, and common practice challenges.

Emmy Graber, MD, MBA, shared the truth behind cosmeceutical trends that patients may ask about from snail mucin to skin care refrigerators.